Reported Tuberculosis in the United States, 2017

Return to Main Menu

Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH)1, Origin of Birth, and Previous History of TB: United States, 1993–2017

Table 8. Tuberculosis Cases and Percentages, by Resistance to Isoniazid (INH), Origin of Birth, and Previous History of TB: United States, 1993–2017
Year All INH-Resistant2 Isoniazid Resistant TB Cases
Total INH-Resistant U.S.-Born INH-Resistant3 Non-U.S.–Born3,4 INH-Resistant
Previous TB No previous TB Previous TB No previous TB Previous TB No previous TB
Eligible No. (%) Eligible No. (%) Eligible No. (%) Eligible No. (%) Eligible No. (%) Eligible No. (%)
1993 1,534 982 161 (16.4) 16,601 1,367 (8.2) 668 83 (12.4) 11,808 789 (6.7) 301 75 (24.9) 4,665 564 (12.1)
1994 1,543 1033 175 (16.9) 16,417 1,352 (8.2) 693 81 (11.7) 11,009 708 (6.4) 336 93 (27.7) 5,291 632 (11.9)
1995 1,351 958 168 (17.5) 16,023 1,173 (7.3) 592 77 (13.0) 10,340 554 (5.4) 364 91 (25.0) 5,652 618 (10.9)
1996 1,284 862 142 (16.5) 15,360 1,133 (7.4) 559 68 (12.2) 9,637 495 (5.1) 303 74 (24.4) 5,676 637 (11.2)
1997 1,195 742 109 (14.7) 14,449 1,078 (7.5) 455 35 (7.7) 8,696 435 (5.0) 286 74 (25.9) 5,708 640 (11.2)
1998 1,120 749 98 (13.1) 13,420 1,011 (7.5) 485 38 (7.8) 7,695 366 (4.8) 262 60 (22.9) 5,692 643 (11.3)
1999 1,000 669 82 (12.3) 12,659 900 (7.1) 382 25 (6.5) 7,011 284 (4.1) 284 55 (19.4) 5,596 614 (11.0)
2000 981 632 84 (13.3) 11,829 889 (7.5) 360 22 (6.1) 6,141 269 (4.4) 272 62 (22.8) 5,659 617 (10.9)
2001 897 629 87 (13.8) 11,514 800 (6.9) 324 28 (8.6) 5,570 241 (4.3) 302 59 (19.5) 5,908 558 (9.4)
2002 912 570 80 (14.0) 10,820 826 (7.6) 303 23 (7.6) 5,059 206 (4.1) 265 57 (21.5) 5,720 619 (10.8)
2003 904 524 65 (12.4) 10,752 823 (7.7) 253 16 (6.3) 4,853 213 (4.4) 271 49 (18.1) 5,869 606 (10.3)
2004 872 537 64 (11.9) 10,482 801 (7.6) 274 15 (5.5) 4,683 214 (4.6) 263 49 (18.6) 5,789 587 (10.1)
2005 842 507 70 (13.8) 10,065 761 (7.6) 240 18 (7.5) 4,396 188 (4.3) 267 52 (19.5) 5,652 567 (10.0)
2006 845 493 67 (13.6) 9,907 770 (7.8) 203 9 (4.4) 4,126 173 (4.2) 289 57 (19.7) 5,765 596 (10.3)
2007 798 496 71 (14.3) 9,646 715 (7.4) 206 14 (6.8) 3,837 163 (4.2) 288 57 (19.8) 5,755 548 (9.5)
2008 836 429 57 (13.3) 9,306 775 (8.3) 170 13 (7.6) 3,647 189 (5.2) 259 44 (17.0) 5,653 585 (10.3)
2009 763 341 52 (15.2) 7,739 651 (8.4) 115 6 (5.2) 3,014 187 (6.2) 225 46 (20.4) 4,717 464 (9.8)
2010 693 359 63 (17.5) 7,769 621 (8.0) 131 13 (9.9) 2,931 164 (5.6) 228 50 (21.9) 4,832 457 (9.5)
2011 754 345 59 (17.1) 7,554 688 (9.1) 137 9 (6.6) 2,702 173 (6.4) 208 50 (24.0) 4,849 515 (10.6)
2012 692 356 55 (15.4) 7,083 637 (9.0) 127 8 (6.3) 2,523 151 (6.0) 229 47 (20.5) 4,560 486 (10.7)
2013 675 301 48 (15.9) 6,866 622 (9.1) 98 8 (8.2) 2,286 131 (5.7) 203 40 (19.7) 4,575 491 (10.7)
2014 691 336 63 (18.8) 6,746 624 (9.2) 95 5 (5.3) 2,187 164 (7.5) 241 58 (24.1) 4,555 460 (10.1)
2015 683 317 51 (16.1) 6,961 631 (9.1) 100 7 (7.0) 2,194 149 (6.8) 217 44 (20.3) 4,762 481 (10.1)
2016 650 300 56 (18.7) 6,687 590 (8.8) 82 6 (7.3) 2,048 124 (6.1) 218 50 (22.9) 4,632 466 (10.1)
2017 608 267 53 (19.9) 6,216 545 (8.8) 53 2 (3.8) 1,744 95 (5.4) 214 51 (23.8) 4,462 449 (10.1)

1Resistance to at least isoniazid. Isolates may be resistant to other drugs. Excludes cases with susceptibility testing not done or unknown for isoniazid. Cases have been susceptibility tested to at least isoniazid and rifampin.
2This column provides an overall total of all INH-resistant cases, including those where previous history of TB is unknown and origin or birth is unknown.
3Excludes cases where previous history of TB is unknown and cases where origin of birth is unknown.
4Includes persons born outside the United States (including the U.S. territories).
Note: Data for all years updated through June 1, 2018.

Page last reviewed: October 22, 2018